Tyra Biosciences, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Tyra Biosciences, Inc. (TYRA) is 1.19B

According to Tyra Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.19B. This represents a change of -27.95% compared to the average of 1.65B of the last 4 quarters.

Tyra Biosciences, Inc. (TYRA) Historical Enterprise Value (quarterly & annually)

How has TYRA Enterprise Value performed in the past?

The mean historical Enterprise Value of Tyra Biosciences, Inc. over the last ten years is 756.23M. The current 1.19B Enterprise Value has changed 57.18% with respect to the historical average. Over the past ten years (40 quarters), TYRA's Enterprise Value was at its highest in in the March 2026 quarter at 2.29B. The Enterprise Value was at its lowest in in the September 2021 quarter at -150456187.23.

Tyra Biosciences, Inc. (TYRA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tyra Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tyra Biosciences, Inc. (TYRA) Average Enterprise Value

How has TYRA Enterprise Value performed in the past?

The current Enterprise Value of Tyra Biosciences, Inc. (TYRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tyra Biosciences, Inc. (TYRA) Enterprise Value vs. Peers

How is TYRA’s Enterprise Value compared to its peers?

Tyra Biosciences, Inc.’s Enterprise Value is greater than Verastem, Inc. (829.16M), greater than ORIC Pharmaceuticals, Inc. (918.41M), greater than ArriVent BioPharma, Inc. (534.15M), greater than Bicara Therapeutics Inc. Common Stock (461.74M), greater than Janux Therapeutics, Inc. (1.07B), greater than MacroGenics, Inc. (80.12M), greater than Cullinan Therapeutics, Inc. (832.57M), less than Nuvation Bio Inc. (1.64B), greater than Kura Oncology, Inc. (840.65M), greater than Foghorn Therapeutics Inc. (96.13M),

Build a custom stock screener for Tyra Biosciences, Inc. (TYRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tyra Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tyra Biosciences, Inc. (TYRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tyra Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.